Endolysins and membrane-active peptides: innovative engineering strategies against gram-negative bacteria

Endolysins, bacteriophage-encoded peptidoglycan hydrolases, offer promising potential in antibacterial therapy, including treatments targeting gram-negative bacteria. While these enzymes naturally act primarily on gram-positive bacteria, their application against gram-negative pathogens is more chal...

Full description

Saved in:
Bibliographic Details
Main Author: Monika Wojciechowska
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2025.1603380/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849696763038924800
author Monika Wojciechowska
author_facet Monika Wojciechowska
author_sort Monika Wojciechowska
collection DOAJ
description Endolysins, bacteriophage-encoded peptidoglycan hydrolases, offer promising potential in antibacterial therapy, including treatments targeting gram-negative bacteria. While these enzymes naturally act primarily on gram-positive bacteria, their application against gram-negative pathogens is more challenging due to the presence of a dual-layer cell membrane, which acts as a protective barrier. However, innovative approaches, such as fusing endolysins with antimicrobial peptides (AMPs), have demonstrated increased efficacy against gram-negative bacteria. Modifying endolysins by introducing hydrophobic properties or positive charges or combining them with agents that disrupt the outer membrane enhances their bactericidal activity. Moreover, phage endolysins that exhibit activity against gram-negative bacteria are a promising source of membrane-active peptides. Identifying new peptide sequences derived from endolysins capable of penetrating the bacterial cell membrane represents a novel and increasingly explored research direction. Studying these innovative strategies had yielded promising results, though the field remains under active investigation and development. Ongoing efforts aim to optimize these approaches to improve their effectiveness against antibiotic-resistant gram-negative bacterial strains, which are particularly difficult to treat with conventional antibiotics. This review summarizes the latest advancements and solutions in the field, highlighting the potential of endolysins and membrane-active peptides as next-generation antibacterial agents.
format Article
id doaj-art-f9d2d76a478a4e5bb860a13c293e413d
institution DOAJ
issn 1664-302X
language English
publishDate 2025-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj-art-f9d2d76a478a4e5bb860a13c293e413d2025-08-20T03:19:21ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2025-06-011610.3389/fmicb.2025.16033801603380Endolysins and membrane-active peptides: innovative engineering strategies against gram-negative bacteriaMonika WojciechowskaEndolysins, bacteriophage-encoded peptidoglycan hydrolases, offer promising potential in antibacterial therapy, including treatments targeting gram-negative bacteria. While these enzymes naturally act primarily on gram-positive bacteria, their application against gram-negative pathogens is more challenging due to the presence of a dual-layer cell membrane, which acts as a protective barrier. However, innovative approaches, such as fusing endolysins with antimicrobial peptides (AMPs), have demonstrated increased efficacy against gram-negative bacteria. Modifying endolysins by introducing hydrophobic properties or positive charges or combining them with agents that disrupt the outer membrane enhances their bactericidal activity. Moreover, phage endolysins that exhibit activity against gram-negative bacteria are a promising source of membrane-active peptides. Identifying new peptide sequences derived from endolysins capable of penetrating the bacterial cell membrane represents a novel and increasingly explored research direction. Studying these innovative strategies had yielded promising results, though the field remains under active investigation and development. Ongoing efforts aim to optimize these approaches to improve their effectiveness against antibiotic-resistant gram-negative bacterial strains, which are particularly difficult to treat with conventional antibiotics. This review summarizes the latest advancements and solutions in the field, highlighting the potential of endolysins and membrane-active peptides as next-generation antibacterial agents.https://www.frontiersin.org/articles/10.3389/fmicb.2025.1603380/fullendolysinspeptidesantimicrobial peptidesbacteriophageantibioticsgram-negative bacteria
spellingShingle Monika Wojciechowska
Endolysins and membrane-active peptides: innovative engineering strategies against gram-negative bacteria
Frontiers in Microbiology
endolysins
peptides
antimicrobial peptides
bacteriophage
antibiotics
gram-negative bacteria
title Endolysins and membrane-active peptides: innovative engineering strategies against gram-negative bacteria
title_full Endolysins and membrane-active peptides: innovative engineering strategies against gram-negative bacteria
title_fullStr Endolysins and membrane-active peptides: innovative engineering strategies against gram-negative bacteria
title_full_unstemmed Endolysins and membrane-active peptides: innovative engineering strategies against gram-negative bacteria
title_short Endolysins and membrane-active peptides: innovative engineering strategies against gram-negative bacteria
title_sort endolysins and membrane active peptides innovative engineering strategies against gram negative bacteria
topic endolysins
peptides
antimicrobial peptides
bacteriophage
antibiotics
gram-negative bacteria
url https://www.frontiersin.org/articles/10.3389/fmicb.2025.1603380/full
work_keys_str_mv AT monikawojciechowska endolysinsandmembraneactivepeptidesinnovativeengineeringstrategiesagainstgramnegativebacteria